Micron Biomedical, a US-based life science company, announced on Wednesday that it has named Brian Bernick, MD as the chairman of the company's board of directors.

Dr Bernick previously founded TherapeuticsMD (NASDAQ TXMD). He has over 25-years of clinical medicine experience and significant business development, investor relations and capital raise experience. He has more than 70 US and foreign patents focusing on drug therapies, devices, and analysis.

Steven Damon, Micron Biomedical CEO, said, 'Dr Brian Bernick has a long-standing record of patient-centred innovation and a unique perspective as both an internationally recognised OBGYN and an entrepreneur bringing self-administered drug delivery innovations to market. As Micron accelerates efforts to commercialise our proprietary needle-free dissolvable technology, Dr Bernick's strong scientific background, as well as his proven ability to implement effective business and marketing strategies across numerous therapeutic areas, are a tremendous asset and complement to an already outstanding board of directors.'